From: Lee mortality index as comorbidity measure in patients undergoing radical cystectomy
Points | Predicted 10-year overall mortality(Cruz et al.[2013]) | 95% CI(Cruz et al.[2013]) | Proportion of events* | Observed 10-year competing mortality | 95% CI | p** |
---|---|---|---|---|---|---|
0 | 2.8% | 1.3-4.2% | 0/8 | 0.0% | NA | 0.0002 |
1 | 4.0% | 2.6-5.4% | 1/12 | 9.4% | 0.0-30.7% | 0.4923 |
2 | 6.0% | 4.8-7.3% | 2/54 | 1.9% | 0.0-5.6% | 0.0088 |
3 | 9.1% | 7.6-11% | 4/59 | 3.5% | 0.0-8.3% | 0.0144 |
4 | 14% | 12-16% | 14/118 | 9.5% | 2.7-16.3% | 0.2134 |
5 | 21% | 19-23% | 20/109 | 17.8% | 9.2-26.4% | 0.4775 |
6 | 30% | 27-33% | 21/103 | 25.0% | 13.9-36.1% | 0.3940 |
7 | 40% | 36-43% | 36/97 | 36.0% | 23.9-48.0% | 0.5321 |
8 | 52% | 48-55% | 22/57 | 32.3% | 17.4-47.1% | 0.0114 |
9 | 62% | 58-66% | 22/52 | 49.8% | 24.1-75.6% | 0.3588 |
10 | 71% | 67-76% | 13/35 | 40.8% | 19.7-61.8% | 0.0060 |
11 | 81% | 76-85% | 12/21 | 55.6% | 21.8-73.5% | 0.0578 |
12 | 85% | 81-90% | 2/8 | 25.0% | 0.0-52.1% | <0.0001 |
13 | 89% | 85-94% | 2/2 | 100% | NA | <0.0001 |
14+ | 95% | 93-98% | 0/0 | NA | NA | NA |